UBS Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-200
| Closed | -$5.96K | – | 10567 |
|
|
2024
Q4 | $5.96K | Hold |
200
| – | – | ﹤0.01% | 8605 |
|
|
2024
Q3 | $3.13K | Hold |
200
| – | – | ﹤0.01% | 8309 |
|
|
2024
Q2 | $3.43K | Sell |
200
-10,800
| -98% | -$190K | ﹤0.01% | 8214 |
|
|
2024
Q1 | $172K | Sell |
11,000
-132,900
| -92% | -$1.95M | ﹤0.01% | 5953 |
|
|
2023
Q4 | $2.15M | Hold |
143,900
| – | – | ﹤0.01% | 3742 |
|
|
2023
Q3 | $2.32M | Buy |
143,900
+57,700
| +67% | +$1.66M | ﹤0.01% | 3295 |
|
|
2023
Q2 | $3.58M | Buy |
86,200
+76,600
| +798% | +$4.76M | ﹤0.01% | 2913 |
|
|
2023
Q1 | $577K | Buy |
9,600
+400
| +4% | +$32K | ﹤0.01% | 4578 |
|
|
2022
Q4 | $675K | Hold |
9,200
| – | – | ﹤0.01% | 4431 |
|
|
2022
Q3 | $699K | Hold |
9,200
| – | – | ﹤0.01% | 4051 |
|
|
2022
Q2 | $639K | Hold |
9,200
| – | – | ﹤0.01% | 4072 |
|
|
2022
Q1 | $762K | Hold |
9,200
| – | – | ﹤0.01% | 4354 |
|
|
2021
Q4 | $691K | Hold |
9,200
| – | – | ﹤0.01% | 4715 |
|
|
2021
Q3 | $1.07M | Sell |
9,200
-40,800
| -82% | -$6.17M | ﹤0.01% | 4146 |
|
|
2021
Q2 | $11.1M | Buy |
+50,000
| New | +$9.73M | ﹤0.01% | 1944 |
|
|
2021
Q1 | – | Sell |
-16,600
| Closed | -$2.87M | – | 9324 |
|
|
2020
Q4 | $2.87M | Buy |
16,600
+2,600
| +19% | +$356K | ﹤0.01% | 3024 |
|
|
2020
Q3 | $1.56M | Hold |
14,000
| – | – | ﹤0.01% | 3293 |
|
|
2020
Q2 | $830K | Hold |
14,000
| – | – | ﹤0.01% | 3668 |
|
|
2020
Q1 | $943K | Sell |
14,000
-12,100
| -46% | -$956K | ﹤0.01% | 3401 |
|
|
2019
Q4 | $2.2M | Buy |
26,100
+14,000
| +116% | +$1.13M | ﹤0.01% | 3460 |
|
|
2019
Q3 | $905K | Buy |
+12,100
| New | +$968K | ﹤0.01% | 4050 |
|
Other funds holding NVCR
SCM
VPM
VCM
QCM